AstraZeneca expects COVID-19 vaccine capacity of 200M a month by April

Published February 11, 2021 06:38 PM By PUSHKALA ARIPAKA, Reuters

LONDON — AstraZeneca expects to produce more than 100 million doses of its COVID-19 vaccine—developed with Oxford University—this month, ramping up to more than 200 million a month by April, CEO Pascal Soriot said on Thursday.

Mene Pangalos, head of BioPharmaceuticals R&D at the British drugmaker earlier said the company expects much-anticipated data for the late-stage US trial of its vaccine before the end of March.

A read-out on data is "only weeks away," he said on a media call after release of the company's 2020 results. — Reuters

View on GMA News